Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to -0.13%.

  • Journey Medical's Return on Capital Employed rose 45.00% to -0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.13%, marking a year-over-year increase of 45.00%. This contributed to the annual value of -0.32% for FY2024, which is 27.00% down from last year.
  • As of Q3 2025, Journey Medical's Return on Capital Employed stood at -0.13%, which was up 21.52% from -0.16% recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Return on Capital Employed registered a high of 0.07% during Q2 2024, and its lowest value of -2.51% during Q2 2023.
  • Its 3-year average for Return on Capital Employed is -0.55%, with a median of -0.16% in 2025.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by 199bps in 2023, then soared by 258bps in 2024.
  • Quarterly analysis of 5 years shows Journey Medical's Return on Capital Employed stood at -0.84% in 2021, then increased by 15bps to -0.69% in 2022, then soared by 62bps to -0.07% in 2023, then decreased by 30bps to -0.37% in 2024, then surged by 45bps to -0.13% in 2025.
  • Its Return on Capital Employed was -0.13% in Q3 2025, compared to -0.16% in Q2 2025 and -0.16% in Q1 2025.